NCT01783015 - Study of Etanercept in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to Adalimumab or Infliximab Plus Methotrexate | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions

Rheumatoid Arthritis

Interventions

DRUG

Etanercept

Etanercept 50 mg once-weekly

DRUG

Etanercept

Etanercept 50 mg once-weekly

DRUG

Placebo

Etanercept placebo once-weekly

DRUG

Placebo

Etanercept placebo once-weekly

Trial Locations (15)

1200

Cliniques Universitaires Saint-Luc / Service de Rhumatologie, Brussels

6100

RK Will Pty Ltd, Victoria Park

29009

Hospital Regional Universitario Carlos Haya. Hospital Civil, Málaga

29010

Hospital Regional Universitario Carlos Haya., Málaga

31048

Bnai Zion Medical Ctr Pharmacy, Haifa

41010

Hospital Infanta Luisa, Seville

44281

Meir Medical Center pharmacy, Kfar Saba

115522

Scientific Institute of Rheumatology of Russian Academy of Medical Science, Moscow

129301

GBOU VPO Moscow State University of Medicine and Dentistry, Moscow

420103

"LLC Research Medical Complex Your Health based on City Clinical Hospital #7", Kazan'

426063

"LLC Alliance Biomedical - Russian Group", Izhevsk

34295 cedex 5

Hopital Lapeyronie, Montpellier

Unknown

Tseung Kwan O Hospital, Tseung Kwan O

Tseung Kwan O Hospital, Tseung Kwan O, NT

08025

Hospital de la Santa Creu i San Pau, Barcelona